AI assistant
Sending…
IN8BIO, INC. — Director's Dealing 2025
May 12, 2025
35200_dirs_2025-05-12_a0f7fc97-1f6c-48af-b2fc-08a32521e751.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2025-05-08
Reporting Person: Epperly Corinne (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-05-08 | Stock Option (right to buy) | $0.17 | A | 63150 | Acquired | 2035-05-08 | Common Stock (63150) | Direct |
Footnotes
F1: One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on June 8, 2025; provided, however, that the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date.